These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9467040)
1. The Will Rogers phenomenon in prostate cancer: a good thing. Gomella LG Cancer J Sci Am; 1998; 4(1):19-21. PubMed ID: 9467040 [No Abstract] [Full Text] [Related]
2. Screening for prostate cancer: the role of prostate-specific antigen. Ferrer RL Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171 [No Abstract] [Full Text] [Related]
4. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73. Kvåle R; Hernes E; Bray F Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155 [No Abstract] [Full Text] [Related]
5. A message from preventive medicine and your physician. Prostate cancer. Prev Med; 2000 Aug; 31(2 Pt 1):101-2. PubMed ID: 10938208 [No Abstract] [Full Text] [Related]
7. What's new in prostate cancer screening and prevention? Klein EA Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036 [TBL] [Abstract][Full Text] [Related]
9. [Prostatic specific antigen in practice in 1997]. Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634 [TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen and screening for early prostate cancer. Davidson P N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919 [No Abstract] [Full Text] [Related]
11. Editorial comment: factor that influence serum prostate-specific antigen levels in terms of maintaining quality within a PSA screening system. Ito K Eur Urol; 2007 Sep; 52(3):714. PubMed ID: 17849514 [No Abstract] [Full Text] [Related]
12. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices. Howard K; Barratt A; Mann GJ; Patel MI Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening. Simon T Mt Sinai J Med; 1996 Mar; 63(2):141. PubMed ID: 8775147 [No Abstract] [Full Text] [Related]
14. Prostate specific antigen screening. Block KI Integr Cancer Ther; 2009 Jun; 8(2):111-2. PubMed ID: 19679618 [No Abstract] [Full Text] [Related]
16. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker. Hamilton RJ; Platz EA; Freedland SJ J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913 [No Abstract] [Full Text] [Related]
17. Screening and early detection for prostate cancer. Magoha GA East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752 [TBL] [Abstract][Full Text] [Related]
18. Kiwi conundrum: Screening for prostate cancer. Kuska B J Natl Cancer Inst; 1997 Jul; 89(14):1000. PubMed ID: 9244811 [No Abstract] [Full Text] [Related]
19. In this issue: mini-theme on geriatric care and cancer screening. Bowman MA; Neale AV J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726 [No Abstract] [Full Text] [Related]
20. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. Ito K; Kakehi Y; Naito S; Okuyama A; Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]